Neal Walker
2018
In 2018, Neal Walker earned a total compensation of $4.4M as President and Chief Executive Officer at Aclaris Therapeutics, a 439% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $221,100 |
|---|---|
| Option Awards | $2,626,344 |
| Salary | $550,000 |
| Stock Awards | $954,288 |
| Other | $11,660 |
| Total | $4,363,392 |
Walker received $2.6M in option awards, accounting for 60% of the total pay in 2018.
Walker also received $221.1K in non-equity incentive plan, $550K in salary, $954.3K in stock awards and $11.7K in other compensation.
Rankings
In 2018, Neal Walker's compensation ranked 2,470th out of 14,244 executives tracked by ExecPay. In other words, Walker earned more than 82.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,470 out of 14,244 | 83rd |
Division Manufacturing | 910 out of 5,765 | 84th |
Major group Chemicals And Allied Products | 311 out of 2,128 | 85th |
Industry group Drugs | 253 out of 1,817 | 86th |
Industry Pharmaceutical Preparations | 196 out of 1,391 | 86th |
Source: SEC filing on April 25, 2019.
Walker's colleagues
We found two more compensation records of executives who worked with Neal Walker at Aclaris Therapeutics in 2018.